Tau PET tracers, [11C]PBB3 and [18F]PM‐PBB3, are able to capture wide‐range tau pathologies in AD, non‐AD tauopathies, and model mice exemplified by rTg4510 and PS19 [58, 65, 90, 104]. This evidence concerns the gene MAPT and Alzheimer disease.